Vildagliptin treatment increased insulin secretion and decreased glucagon secretion in hyperglycemia, providing a clear explanation for the improvement in glucose tolerance that persist for at least 2 years that has been discussed above. The gene discussed is INS; the disease is Hyperglycemia.